1. Guerin AP, Blacher J, Pannier B, et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103 p. 987–92.
2. Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113 (9): 1213–25.
3. Roman MJ, Devereux RB, Kizer JR, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007; 50: 197–203.
4. Wang KL, Cheng HM, Chuang HM, et al. Central or peripheral systolic or pulse pressure: which one best relates to target organs future mortality? J Hypertens 2009; 27: 461–7.
5. Vlachopoulos C, Aznaouridis K, Stefanadis C, et al. Prediction of cardiovascular events and all cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010; 31: 1865–71.
6. London GM, Blacher J, Pannier B, et al. Arterial wave reflections and survival in endstage renal failure. Hypertension 2001; 38: 434–8.
7. Tropeano Al, Boutouyrie P, Pannier B, et al. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension 2006; 48: 80–6.
8. Mackenzie IS, McEniery CM, Dhakam Z, et al. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension 2009; 54 p. 409–13.
9. Tomiyama H, Yoshida M, Yamada J. Arterial-cardiac destiffening following long-term antihypertensive treatment. Am J Hypertens 2011; 24: 1080–6.
10. Kithas PH, Supiano MA. Spironolactone and hydrochlorthiazide decrease vascular stiffness and blood pressure in geriatric hypertension. J Am Geriatric Soc 2010; 58: 1327–32.
11. Palombo C, Malshi E, Morizzo C. Arterial wave reflection during antihypertensive therapy with barnidipine: a 6-month open label study using an integrated cardiovascular ultrasound approach in patients with newly diagnosed hypertension. Clin Ther 2009; 31 (12): 2873–85.
12. Dart AM, Cameron JD, Gatzka CD. Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension 2007; 49: 1242–7.
13. Asmar RG, London GM, O´Rourke ME, et al. Improvement in blood pressure, arterial stiffness and wave reflections with a very low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenolol. Hypertension 2001; 38 (4): 922–6.
14. Boutouyrier P, Achouba A, Trunet P, et al. Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipineatenolol combination: the EXPLOR study. Hypertension 2010; 55 (6): 1314–22.
15. Topouchian J, Asmar R, Sayegh F. Changes in arterial structure and function under trandolapril-verapamil combination in hypertension. Stroke 1999; 30 (5): 1056–64.
16. Matzui Y, Eguchi K, O’Rourke M. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension 2009; 54: 716–23.
17. Mahmud A, Feely J, Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection. Am J Hypertens 2008; 21: 663–7.
18. Shah NK, Smith SM, Nichols WW. Carvedilol reduces aortic wave reflection and improves left ventricular/vascular coupling: a comparison with atenolol (CENTRAL study). J Clin Hypertens 2011; 13 (12): 917–24.
